Insights from CEO Lone Carlbom
The biopharmaceutical landscape is evolving rapidly. While traditional monoclonal antibodies (mAbs) remain a cornerstone of [...]
The biopharmaceutical landscape is evolving rapidly. While traditional monoclonal antibodies (mAbs) remain a cornerstone of [...]
Zepteon, Inc. partners with Bio-Works Technologies AB to expand distribution of Glycap-3A chromatography columns, enhancing market reach in the US and EU.
Bio-Works Technologies AB publishes its Annual Report for 2023, detailing the company's continued journey and strategic developments.
A newly issued patent by the Swedish Intellectual Property Office grants Bio-Works Technologies AB rights to manufacture agarose beads using natural vegetable oils instead of fossil-based oils, enabling greener chromatography.
Bio-Works Technologies AB publishes its Annual Report for 2022, reflecting a year of meaningful progress for the company.
Bio-Works provides protein purification training to African research centers, building scientific capacity across the continent.
Bio-Works expands its European distribution network by partnering with BIA d.o.o. to cover Croatia and Slovenia.
Bio-Works signs a distribution agreement with S. Amit Speciality Chemicals to strengthen its presence in the Indian market.
Bio-Works signs an exclusive distribution deal with MicroAnalytix to serve customers in Australia and New Zealand.
Bio-Works Technologies AB successfully passes its annual ISO 9001:2015 audit, reaffirming its quality management commitment.